Less understood issues: p21(Cip1) in mitosis and its therapeutic potential

N-N Kreis1, F Louwen1, J Yuan1

  • 1Department of Gynecology and Obstetrics, J.W. Goethe-University, Frankfurt, Germany.

Oncogene
|May 27, 2014
PubMed

Insights

The cell cycle regulator p21 (also known as Cip1) is crucial for mitosis. Loss of p21 causes mitotic defects and genomic instability, while its stabilization in tumor cells suggests a role in cancer therapy.

Area of Science:

  • Cell Biology
  • Molecular Oncology

Background:

  • p21 (Cip1) is a key regulator of cellular processes, with dual roles as a tumor suppressor and oncogene.
  • Its role in mitosis, though proposed, has not been systematically investigated.
  • p21 expression is modulated by p53-dependent and -independent pathways in response to cellular stress.

Purpose of the Study:

  • To systematically investigate the function of p21 in mitosis.
  • To elucidate the role of p21 in mitotic progression and genomic stability.
  • To explore the therapeutic potential of p21 in cancer treatment.

Main Methods:

  • Biochemical assays to determine p21 binding and inhibition of Cdk1/cyclin B1 activity.
  • Analysis of mitotic progression, chromosome segregation, and cytokinesis in cells with and without p21.
  • Investigation of p21 stabilization and localization in mitotic tumor cells treated with mitotic agents.

Main Results:

  • p21 binds to and inhibits Cdk1/cyclin B1, ensuring precise mitotic progression.
  • Loss of p21 leads to prolonged mitosis, chromosome segregation errors, and cytokinesis failure, promoting genomic instability.
  • p21 is stabilized in the cytoplasm of mitotic tumor cells treated with paclitaxel or mitotic kinase inhibitors, correlating with cell survival.

Conclusions:

  • p21 plays a critical role in regulating mitosis and maintaining genomic stability.
  • Stabilized p21 in tumor cells suggests its involvement in resistance to mitotic agents and potential as a therapeutic target.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

2.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K